The Board's Role in Reinvention

Authored by Emily Jones, Senior Editor , Criticaleye

Speakers at Criticaleye’s Chair & NED Retreat discuss the Board’s integral role in leading successful transformation, and how to maintain the relationships that are crucial to the process.

Featuring commentary from: 

Devyani Vaishampayan, NED, Saietta Group and Board Mentor, Criticaleye

Jonathan Keane, Senior Managing Director, Strategy Consulting Lead for the UK & Ireland & Global Luminary Network Lead, Accenture

Steve Pateman, NED, Bank of Ireland

Matthew Blagg, CEO Criticaleye


Share this with your Community


Contributors
Devyani Vaishampayan
Board Mentor
Criticaleye
Jonathan Keane
Strategy and Consulting Lead, UK, Ireland & Africa and Global Luminary Network Lead
Accenture
Matthew Blagg
CEO
Criticaleye
Steve Pateman
Non-executive Director
Bank of Ireland


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Criticaleye Asia Podcast - Chairing for Impact: Leadership Lessons from Ray Ferguson, Global Board Chair

In this episode, Yu-Wen Hsiao, Marketing and Communications Manager, APAC at Criticaleye, speaks with Ray Ferguson, Global Board Chair and seasoned international banker, shares his perspective on how CEOs and Boards ...


Click here to download this insight

VIEWPOINTS | Five Tips For Being an Effective Chair

Paul Lester has Chaired an impressive array of publicly listed, private equity-backed and family-owned businesses over the years, such as FirstPort, Readypower, Forterra, and Essentra.      Cur...


Click here to download this insight

High-energy Leadership

Donal Murphy, CEO of DCC plc, has led a large-scale transformation over the last 18 months. He talks to Criticaleye's Marc Barber about why the company's future lies in energy  As a young man...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 222




Worldpay Lightsource bp NatWest Group Drax Group plc Rolls-Royce E.ON UK AlixPartners Hitachi Solutions NATS LACE Partners London Stock Exchange Group Mayborn Group Legal & General Canaccord Genuity Group Inc British Land GlaxoSmithKline plc Aldermore Group